MedTrace Logo

Determination of the Validity of One-Minute Sit-to-Stand Test in Obese and Overweight Children and Adolescents

NCT05392920 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2022-07-08

No results posted yet for this study

Summary

Obese individuals need to be evaluated comprehensively before exercise programs are determined. Determination of exercise intolerance is important for the detection of functional limitations. One minute sit to stand test (1MSTST) can be used as an alternative to cardiopulmonary exercise tests (CPET) or field tests. It is easy to use, quick to apply, valid and reliable, and applicable even in small areas. In addition, it is a simple assessment adequate for children's needs and behaviors and can be easily applied both in the clinic and at home, making it easier to use in children. Studies have shown that 1MSTST is a valid test in chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung disease, and, healthy children and adolescents. However, no study has been found regarding the validity of its use in obese children and adolescents.The aim of our study is to investigate the validity and reliability of 1MSTST in overweight-obese children and adolescents.

Conditions

  • Obese
  • Child Obesity
  • Adolescent Obesity
  • Exercise Capacity

Interventions

OTHER

assessment study

there is no intervention in this study

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Goksen Kuran Aslan, PT, phD · Istanbul University - Cerrahpasa

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-08
Primary Completion
2022-10-02
Completion
2022-11-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05392920 on ClinicalTrials.gov